James Gomes
James Gomes
Associate Professor

1999, Ph.D., Environmental Health Middlesex University, United Kingdom
1996, M.Sc., Environmental Health, Middlesex University, United Kingdom
1982, M.Sc., Clinical Chemistry, Bombay University, Bombay, India

Room
Office: THN 210
Endotox Lab: 451 Smyth Road, RGN 2217
Phone
613-562-5800 ext. 8426 (office)
613-562-5632 (fax)
613-562-5800 ext. 4930 (laboratory)


Biography

Dr. James Gomes is an associate professor at the Interdisciplinary School of Health Sciences of the University of Ottawa. He teaches determinants of health, epidemiology, and environmental health at the undergraduate level, and toxicology and risk assessment at the graduate level. He supervises graduate students in the population health program, the epidemiology program, and the certificate program in population health risk assessment. Dr. Gomes conducts research in environmental and occupational health and is affiliated with the Department of Epidemiology and Community Medicine, the Institute of Population Health, the Institute of Environment, and the Center for Advanced Research in Environmental Genomics. He is also on the expert panel of Risk Science International, and is consulted by Health Canada and the Public Health Agency of Canada on environmental health risk assessment issues. 

His graduate training centred on environmental health and during his post-doctoral training, he studied prostate cancer with a focus on molecular epidemiology and molecular toxicology. His primary area of research is population health risk assessment, with emphasis on occupational and environmental exposure and the etiology of adverse health effects. His current research looks at molecular epidemiology and molecular toxicology as a way to understand the role of endocrine disrupting chemicals in initiating and promoting hormonal cancers and birth defects. He is also interested in biomarker discovery and toxicity assessment of environmental and occupational exposures. Dr. Gomes is committed to combining population health studies with laboratory research by applying bench research to population health problems and vice-versa.

Professor Gomes is accepting new students for thesis supervision.

Research interests

  • Environmental health
  • Epidemiology of environmental and occupational health
  • Toxicology: toxicity of chemicals and adverse health effects, molecular carcinogenesis
  • Impact of environment on human health

Publications

  • Khan SM*, Krewski D, Gomes J, Deonandan R. Radon, an invisible killer in Canadian homes: perceptions of Ottawa-Gatineau residents. Canadian Journal of Public Health [Internet]: 1-10; 2018 Nov 19 [cited 2019 Jan 10]; Available from: http://link.springer.com/10.17269/s41997-018-0151-5. (Funding Gomes Research Chair, Contribution 30%, Impact factor 1.454).
  • Khan SM*, Gomes J. Drought in Ethiopia: A Population Health Equity Approach to Build Resilience for the Agro-Pastoralist Community. Global Journal of Health Science [Internet]. 2019 Jan 10 [cited 2019 Jan 10];11(2): 42-54. Available from: http://www.ccsenet.org/journal/index.php/gjhs/issue/view/0/2018. (Funding Gomes Research Chair, Contribution 30%, Impact factor 3.3).
  • Benrahim T, Bouvard V, El-Ghissassi F, Espina C, Feletto E, Gomes J, Gosse Y, Gyha N, Gayton K, Huybrecht I, Loomis D, Matlock H, Mullee A, Romiea I, SantaMaria-Ulloa C, Stephien M, Staraif K. IARC Monographs on the evaluation of carcinogenic risks to humans: Red meat and processed meat. Monograph vol 114. 2017 (Lancet.com/oncology vol 16; 1599. 2015. Funding RSI, Contribution 20%, Impact factor 53.254).
  • Sandu P*, Nameem MM, Lu C, Kumarathasan P, Gomes J, Basak A. Ser422 phosphorylation blocks human Tau cleavage by caspace-s: biochemical implications to Alzheimer’s Disease. Bioorg Med Chem Lett. 2017 Feb1;27(3):642-652. Doi: 10.1016/jbmcl 2016.11.087. Epub 2016 Dec 2. (Funding NSERC, Contribution 30%, Impact factor 2.44).
  • Hersi M*, Irvine B, Gupta P, Gomes J, Birkett N, Krewski D. Risk Factors Associated with the Onset of Alzheimer’s Disease: a Systematic Review of the evidence. 2017 NeuroToxicology 2017; 61:143-187 http://dx.doi.10.1016/jneuro 2017.03.006. Epub 2017 Mar 29. (Funding PHAC, Contribution 60%, Impact factor 3.076).
  • Krewski D, Barakat-Hadad C, Donnan J, Martion R, Pringsheim T, Tremlett H, van Lieshout P, Walsh SJ, Birkett NJ, Gomes J, Little J, Bowen S, Candundo H, Chao T-K, Collins K, Crispo JAG, Duggan T, El-Sherif R, Farhat N, Fortin Y, Gaskin J, Gupta P, Hersi M, Poon WH, Hu J, Irvine B, Jahanfar S, MacDonald D, McKay K, Morrissey A, Quach P, Rashid R, Shin S, Sikora L, Tkachuk S, Taher MK, Wang M-D, Darshan, Cashman NR. Determinants of neurological disease: Synthesis of systematic reviews. NeuroToxicology 2017; 61: 266-289 http://dx.doi.10.1016/j.neuro.2017.04.002. Epub 2017 Apr 12. (Funding PHAC, Contribution 30%, Impact factor 3.076).
  • Hersi M*, Quach P, Wang M-D, Gomes J, Gaskin J, Krewski D. Systematic review of factors associated with the onset and progression of neurological conditions in humans: A methodological overview NeuroToxicology 2017; 61:12-18. http://dx.doi.org/doi:10.1016/j.neuro.2016.06.017. Epub 2016 Jul 1. (Funding PHAC, Contribution 40%, Impact factor 3.076).
  • Gaskin J, Gomes J, Darshan S, Krewski D. Burden of neurological conditions in Canada. NeuroToxicology 2017; 61:2-10. http://dx.doirg/10.1016/j.neuro.2016.05.001. Epub 2016. (Funding PHAC, Contribution 30%, Impact factor 3.076).
  • Quach P*, El-Sherif R, Gomes J, Krewski D. A systematic review of the risk factors associated with the onset and progression of primary brain tumors. NeuroToxicology 2017; 61: 214-232. http://dx.doi.org/10.1016/j.neuro.2016.05.009. Epub 2016 Jul 1. (Funding PHAC, Contribution 40%, Impact factor 3.076).
  • Wang M-D*, Little J, Gomes J, Cashman N, Krewski D. Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analyses. Neurotoxicology. 2017; 61: 101--130 http://dx.doi.org:10.1016/j.neuro.2016.06.015. Epub 2016 Jul 1 (Funding PHAC, Contribution 40%, Impact factor 3.076).
  • Little J, Barakat-Haddad C, Martino R, Pringsheim T, Tremlatt H, McKay K, van Lieshout P, Walsh SJ, Gomes J, Krewski D. Genetic variations associated with the occurrence and progression of neurological disorders. NeuroToxicology 2017; 61: 243-264 http://dx.doi.org/10.1016/j.neuro.2016.09.018.